These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8548799)

  • 1. The 3' enhancer region determines the B/T specificity and pro-B/pre-B specificity of immunoglobulin V kappa-J kappa joining.
    Hiramatsu R; Akagi K; Matsuoka M; Sakumi K; Nakamura H; Kingsbury L; David C; Hardy RR; Yamamura K; Sakano H
    Cell; 1995 Dec; 83(7):1113-23. PubMed ID: 8548799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ig kappa 3'-enhancer triggers gene expression in early B lymphocytes but its activity is enhanced on B cell activation.
    Meyer KB; Teh YM; Neuberger MS
    Int Immunol; 1996 Oct; 8(10):1561-8. PubMed ID: 8921435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer.
    Roque MC; Smith PA; Blasquez VC
    Mol Cell Biol; 1996 Jun; 16(6):3138-55. PubMed ID: 8649425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YY1 binds to the E3' enhancer and inhibits the expression of the immunoglobulin κ gene via epigenetic modifications.
    Zhou X; Xian W; Zhang J; Zhu Y; Shao X; Han Y; Qi Y; Ding X; Wang X
    Immunology; 2018 Dec; 155(4):491-498. PubMed ID: 30098214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activating transcription factor 1 and cyclic AMP response element modulator can modulate the activity of the immunoglobulin kappa 3' enhancer.
    Pongubala JM; Atchison ML
    J Biol Chem; 1995 Apr; 270(17):10304-13. PubMed ID: 7730336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PU.1 binding site is a cis-element that regulates pro-B/pre-B specificity of Vkappa-Jkappa joining.
    Hayashi R; Takemori T; Kodama M; Suzuki M; Tsuboi A; Nagawa F; Sakano H
    J Immunol; 1997 Nov; 159(9):4145-9. PubMed ID: 9379006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Igκ gene enhancers, E3' and Ed, are essential for triggering transcription.
    Zhou X; Xiang Y; Garrard WT
    J Immunol; 2010 Dec; 185(12):7544-52. PubMed ID: 21076060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B lineage-restricted rearrangement of a human Ig kappa transgene.
    Cavelier P; Nato F; Coquilleau I; Rolink A; Rougeon F; Goodhardt M
    Eur J Immunol; 1997 Jul; 27(7):1626-31. PubMed ID: 9247570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new hypersensitive site, HS10, and the enhancers, E3' and Ed, differentially regulate Igκ gene expression.
    Zhou X; Xiang Y; Ding X; Garrard WT
    J Immunol; 2012 Mar; 188(6):2722-32. PubMed ID: 22323542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin kappa light chain gene promoter and enhancer are not responsible for B-cell restricted gene rearrangement.
    Goodhardt M; Babinet C; Lutfalla G; Kallenbach S; Cavelier P; Rougeon F
    Nucleic Acids Res; 1989 Sep; 17(18):7403-15. PubMed ID: 2508061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.
    Park K; Atchison ML
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9804-8. PubMed ID: 1946405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.
    Hodawadekar S; Park K; Farrar MA; Atchison ML
    J Immunol; 2012 Mar; 188(5):2276-84. PubMed ID: 22279106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of the developmentally controlled immunoglobulin kappa 3' enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors.
    Pongubala JM; Atchison ML
    Mol Cell Biol; 1991 Feb; 11(2):1040-7. PubMed ID: 1899281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.
    Pongubala JM; Nagulapalli S; Klemsz MJ; McKercher SR; Maki RA; Atchison ML
    Mol Cell Biol; 1992 Jan; 12(1):368-78. PubMed ID: 1729611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin remodeling at the Ig loci prior to V(D)J recombination.
    Maës J; O'Neill LP; Cavelier P; Turner BM; Rougeon F; Goodhardt M
    J Immunol; 2001 Jul; 167(2):866-74. PubMed ID: 11441093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. V(D)J recombination frequency is affected by the sequence interposed between a pair of recombination signals: sequence comparison reveals a putative recombinational enhancer element.
    Roch FA; Hobi R; Berchtold MW; Kuenzle CC
    Nucleic Acids Res; 1997 Jun; 25(12):2303-10. PubMed ID: 9235545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced rearrangement of kappa genes in the BLIN-1 human pre-B cell line correlates with germline J-C kappa and V kappa transcription.
    Martin D; Huang RQ; LeBien T; Van Ness B
    J Exp Med; 1991 Mar; 173(3):639-45. PubMed ID: 1900078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of B cells in scid mice with immunoglobulin transgenes: implications for the control of V(D)J recombination.
    Chang Y; Bosma GC; Bosma MJ
    Immunity; 1995 Jun; 2(6):607-16. PubMed ID: 7796294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo occupancy of the kappa light chain enhancers in primary pro- and pre-B cells: a model for kappa locus activation.
    Shaffer AL; Peng A; Schlissel MS
    Immunity; 1997 Feb; 6(2):131-43. PubMed ID: 9047235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-level rearrangement and transcription of yeast artificial chromosome-based mouse Ig kappa transgenes containing distal regions of the contig.
    Li S; Hammer RE; George-Raizen JB; Meyers KC; Garrard WT
    J Immunol; 2000 Jan; 164(2):812-24. PubMed ID: 10623827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.